SLAYBACK PHARMA Trademark

Trademark Overview


On Wednesday, December 18, 2019, a trademark application was filed for SLAYBACK PHARMA with the United States Patent and Trademark Office. The USPTO has given the SLAYBACK PHARMA trademark a serial number of 88731294. The federal status of this trademark filing is REGISTERED as of Tuesday, April 20, 2021. This trademark is owned by Slayback Pharma Limited Liability Company. The SLAYBACK PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of cardiovascular disorders, allergies, anaphylaxis, central nervous system disorders, peripheral nervous system disorders, reproductive health disorders, electrolytic imbalance, caloric imbalance, obesity, nutritional disorders, autoimmune disorders, endocrine disorders, gastrointestinal disorders, inflammatory disorders, dermatological disorders, infectious diseases, hormonal imbalance, pain, complications arising from organ transplantation, cancer, pulmonary disorders, renal disorders, urinary system disorders, ophthalmic disorders, otic disorders, sense organ disorders, dental disorders, musculoskeletal disorders, diabetic disorders, neuromuscular disorders, bone disorders, blood disorders, metabolic disorders, psychosis; pharmaceutical drugs, preparations and medications for use in sedation, analgesia, anaesthesia; pharmaceutical drugs, preparations and medications for use in the ...
slayback pharma

General Information


Serial Number88731294
Word MarkSLAYBACK PHARMA
Filing DateWednesday, December 18, 2019
Status700 - REGISTERED
Status DateTuesday, April 20, 2021
Registration Number6330766
Registration DateTuesday, April 20, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of cardiovascular disorders, allergies, anaphylaxis, central nervous system disorders, peripheral nervous system disorders, reproductive health disorders, electrolytic imbalance, caloric imbalance, obesity, nutritional disorders, autoimmune disorders, endocrine disorders, gastrointestinal disorders, inflammatory disorders, dermatological disorders, infectious diseases, hormonal imbalance, pain, complications arising from organ transplantation, cancer, pulmonary disorders, renal disorders, urinary system disorders, ophthalmic disorders, otic disorders, sense organ disorders, dental disorders, musculoskeletal disorders, diabetic disorders, neuromuscular disorders, bone disorders, blood disorders, metabolic disorders, psychosis; pharmaceutical drugs, preparations and medications for use in sedation, analgesia, anaesthesia; pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of senile disorders, sleep disorders, dementia, congenital disease disorders, abnormal gene disorders, hair growth disorders, gynaecological diseases, obstetric disorders, withdrawal syndromes, hormonal disorders, urogenital organ disorders, sexual dysfunction, nausea and vomiting, emesis, migraine, edema, multiple sclerosis, chronic obstructive pulmonary disorder, depression, pregnancy, spasms, hypertension, hypotension, angioedema, fungal diseases, fertility disorders, hyperglycemia, hypoglycemia, post-operative disorders, arthritis, psoriasis and localized fat deposits; pharmaceutical and biological preparations for use in diagnosis, namely, for use as X-ray contrast reagents
NOT AVAILABLE"PHARMA"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 21, 2019
Primary Code005
First Use Anywhere DateWednesday, November 30, 2016
First Use In Commerce DateFriday, November 30, 2018

Trademark Owner History


Party NameSlayback Pharma Limited Liability Company
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressPrinceton, NJ 08540

Party NameSlayback Pharma Limited Liability Company
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPrinceton, NJ 08540

Trademark Events


Event DateEvent Description
Saturday, December 21, 2019NEW APPLICATION ENTERED
Saturday, December 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 20, 2020ASSIGNED TO EXAMINER
Friday, February 21, 2020NON-FINAL ACTION WRITTEN
Friday, February 21, 2020NON-FINAL ACTION E-MAILED
Friday, February 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 24, 2020NON-FINAL ACTION WRITTEN
Thursday, February 11, 2021TEAS AMENDMENT OF USE RECEIVED
Thursday, September 24, 2020NON-FINAL ACTION E-MAILED
Thursday, September 24, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 13, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Friday, February 12, 2021USE AMENDMENT FILED
Friday, February 12, 2021AMENDMENT TO USE PROCESSING COMPLETE
Friday, March 12, 2021USE AMENDMENT ACCEPTED
Monday, March 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 16, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 18, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 17, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, March 17, 2021ASSIGNED TO LIE
Tuesday, July 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 16, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 16, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 20, 2021REGISTERED-SUPPLEMENTAL REGISTER